Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Other Non-Current Liabilities (2016 - 2018)

OptimizeRx's Other Non-Current Liabilities history spans 9 years, with the latest figure at $1.3 million for Q2 2018.

  • For Q2 2018, Other Non-Current Liabilities fell 43.93% year-over-year to $1.3 million; the TTM value through Jun 2018 reached $1.3 million, down 43.93%, while the annual FY2017 figure was $1.3 million, 43.93% down from the prior year.
  • Other Non-Current Liabilities for Q2 2018 was $1.3 million at OptimizeRx, roughly flat from $1.3 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $3.1 million in Q1 2014 and bottomed at $1.3 million in Q4 2017.
  • The 5-year median for Other Non-Current Liabilities is $2.3 million (2016), against an average of $2.2 million.
  • The largest annual shift saw Other Non-Current Liabilities plummeted 88.24% in 2014 before it rose 8.79% in 2015.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $2.2 million in 2014, then increased by 8.18% to $2.3 million in 2015, then dropped by 1.51% to $2.3 million in 2016, then plummeted by 43.93% to $1.3 million in 2017, then changed by 0.0% to $1.3 million in 2018.
  • Per Business Quant, the three most recent readings for OPRX's Other Non-Current Liabilities are $1.3 million (Q2 2018), $1.3 million (Q1 2018), and $1.3 million (Q4 2017).